The use of positive inotropes in end-of-life heart failure care

Current Heart Failure Reports

Volumn 4, Issue 3, 2007, Pages 158-163

  Nauman, Deirdre J ^a   Hershberger, Ray E ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; INOTROPIC AGENT;

CONTINUOUS INFUSION; DEATH; DRUG DOSE INCREASE; DRUG WITHDRAWAL; HEALTH CARE PERSONNEL; HEART FAILURE; HUMAN; LIFE EXPECTANCY; OUTPATIENT CARE; PATIENT CARE; PATIENT SELECTION; REVIEW;

CARDIOTONIC AGENTS; HEART FAILURE; HUMANS; PALLIATIVE CARE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 34848886851     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-007-0035-0     Document Type: Review

References (25)

1. Rosamond W, Flegal K, Friday G, et al.: American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:e69-171.
2. Ørn S, Dickstein K: How do heart failure patients die? Eur Heart J 2002, 4 (Suppl D):D59-D65.
3. Bardy GH, Lee KL, Mark DB, et al.: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Medi 2005, 352:225-237.
4. Hunt SA, Abraham WT, Chin MH, et al.: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2005, 112:e154-235. This work defines recommendations for optimal care of chronic heart failure and discusses evidence supporting current guidelines.
5. Hershberger RE, Nauman D, Walker TL, et al.: Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J Card Fail 2003, 9:180-187.
6. Rose EA, Gelijns AC, Moskowitz AJ, et al.: Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001, 345:1435-1443.
7. Hobbs FDR: The scale of heart failure: diagnosis and management issues for primary care. Heart 1999, 82(Suppl IV):IV8-IV10.
8. Zambroski CH, Moser DK, Roser LP, et al.: Patients with heart failure who die in hospice. Am Heart J 2005, 149:558-564.
9. Goodlin SJ, Hauptman PJ, Arnold R, et al.: Consensus statement: Palliative and supportive care in advanced heart failure. J Card Fail 2004, 10:200-209. This paper summarizes the results of a multidisciplinary conference convened to define current practices in palliative care of end stage heart failure. The article also identifies barriers to care and areas of suggested research.
10. Teno JM, Weitzen S, Fennel ML, et al.: Dying trajectory in the last year of life: does cancer trajectory fit other diseases? J Palliat Med 2001, 4:457-464.
11. McClung JA: End-of-life care in the treatment of heart failure in the elderly. Clin Geriatr Med 2007, 23:235-248.
12. Kutner JS, Cordt TK, Nowels DE: Sympton burden at the end of life:hospice providers' perceptions. J Palliat Med 2001, 21:473-480.
13. Gibbs JS, McCoy AS, Gibbs LM, et al.: Living with and dying from heart failure: the role of palliative care. Heart 2002, 88(Suppl 2):ii36-39.
14. Harjai KJ, Mehra MR, Ventura HO, et al.: Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes. Chest 1997, 112:1298-1303.
15. Sindone AP, Keogh AM, Macdonald PS, et al.: Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy. Am Heart J 1997, 134:889-900.
16. Upadya S, Lee FA, Saldarriaga C, et al.: Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure. J Heart Lung Transplant 2004, 23:466-472.
17. Brozena SC, Twomey C, Goldberg LR, et al.: A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home. J Heart Lung Transplant 2004, 23:1082-1086.
18. Rich MW, Shore BL: Dobutamine for patients with end-stage heart failure in a hospice program? J Palliat Med 2003, 6:93-97.
19. Jimenez J, Jara J, Bednar B, et al.: Long-term (> 8 weeks) home inotropic therapy as destination therapy in patients with advanced heart failure or as bridge to heart transplantation. International J Cardiol 2005, 99:47-50.
20. Teuteberg JJ, Lewis EF, Nohria A, et al.: Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail 2006, 12:47-53.
21. Felker GM, O'Connor CM: Inotropic therapy for heart failure: an evidence-based approach. Am Heart J 2001, 142:393-401.
22. Hauptman PJ, Mikolajczak P, George A, et al.: Chronic inotropic therapy in end-stage heart failure. Am Heart J 2006, 152:1096.e1-8.
23. POLST.org. Physician Orders for Life-Sustaining Treatment Program. http://www.ohsu.edu/ethics/polst. Accessed March 7, 2007.
24. Goldstein NE, Lampert R, Bradley E, et al.: Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004, 141:835-838.
25. Irvine J, Dorian P, Baker B, et al.: Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 2002, 144:282-289.